Similar Papers

Paper Title
Journal
Date
Author
Serum HE4 predicts progestin treatment response in endometrial cancer and atypical hyperplasia: A prognostic study.
Chloe E Barr ... James Bolton
BJOG : an international journal of obstetrics and gynaecology | VOL. 130
Chloe E Barr, et. al.Chloe E Barr ... James Bolton
15 Feb 2023
Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study
Gianfranco Scarselli ... Massimiliano Fambrini
Fertility and Sterility | VOL. 95
Gianfranco Scarselli, et. al.Gianfranco Scarselli ... Massimiliano Fambrini
19 Aug 2010
Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience.
Sumaya Shikeli ... Vaidyanathan Gowri
JBRA Assisted Reproduction | VOL. 24
Sumaya Shikeli, et. al.Sumaya Shikeli ... Vaidyanathan Gowri
01 Jan 2020
Risk of Discovering Endometrial Carcinoma or Atypical Hyperplasia during Hysteroscopic Surgery in Postmenopausal Women
Aubert Agostini ... Bernard Blanc
American Association of Gynecologic Laparoscopists | VOL. 8
Aubert Agostini, et. al.Aubert Agostini ... Bernard Blanc
01 Nov 2001
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
Sara Corvigno ... Hanna Dahlstrand
Gynecologic Oncology | VOL. 193
Sara Corvigno, et. al.Sara Corvigno ... Hanna Dahlstrand
01 Feb 2025
Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.
Andrea Neilson ... Jessica N Mcalpine
Gynecologic oncology | VOL. 193
Andrea Neilson, et. al.Andrea Neilson ... Jessica N Mcalpine
01 Feb 2025
What happens after menopause? (WHAM): A prospective controlled study of cognition 24months after premenopausal risk-reducing salpingo-oophorectomy.
Pauline M Maki ... Martha Hickey
Gynecologic oncology | VOL. 193
Pauline M Maki, et. al.Pauline M Maki ... Martha Hickey
01 Feb 2025
Barriers to early detection: Insurance denials for breast MRI screening in women with germline BRCA1/2 mutations
S Gordhandas ... E Aviki
Gynecologic Oncology | VOL. 193
S Gordhandas, et. al.S Gordhandas ... E Aviki
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.